Skip to main content
  1. Aggrego Conference Hub
  2. Ash Annual Meeting & Exposition
  3. Updates In Mantle Cell Lymphoma

Updates in Mantle Cell Lymphoma

Studying the Safety and Efficacy of Combo Treatment Zandelisib With Zanubrutinib in Patients with R/R Follicular Lymphoma or Mantle Cell Lymphoma
Aggrego Oncology
1m ago
blood tubes in a lab for research.
Adding Ibrutinib to Induction and Maintenance Improves FFS in Mantle Cell Lymphoma
Cancer Therapy Advisor
1m ago
treatment
BTK Inhibitor With CAR-T Cell Therapy Deemed Effective in Relapsed/Refractory MCL
Cancer Therapy Advisor
1m ago
Closeup of doctor wearing surgical gloves working with vials of solution.
Will Ibrutinib Replace Stem Cell Transplantation as First-Line Treatment for Mantle Cell Lymphoma?
The ASCO Post
1m ago
Scientist wearing surgical gloves working with vials in a lab.
Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial
Blood
1m ago
IV
Gilead and Kite Oncology Demonstrate Transformative Impact of Cell Therapy and Promise of Blood Cancer Portfolio at ASH 2022
Gilead
1m ago
Scientist wearing surgical gloves working with vials in a lab.
AstraZeneca Showcases Strength of Hematology Portfolio and Pipeline Across Multiple Hard-to-Treat Conditions at ASH 2022
AstraZeneca
1m ago
woman in lab
First-Line Bendamustine-Rituximab-Based Induction Followed By Rituximab ± Lenalidomide Consolidation for MCL: Phase 2 Trial Results
Aggrego Oncology
1m ago
syringe and pills
Glofitamab Monotherapy Demonstrates High and Durable Complete Response Rates in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Aggrego Oncology
1m ago
red blood cells

Footer branding


Footer main navigation

  • About Us
  • Contact Us
  • Privacy Policy
  • Sign in

HMP Global Products

  • HMP Global Learning Network
  • Consultant360
  • VRTX

Copyright branding

© 2023 HMP Global. Aggrego is a trademark of HMP Global. All Rights Reserved.

<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->

Home

Site branding - mobile

Upper navigation

  • Today
    Today
  • Following
    Following
  • Specialties
    Specialties

Main navigation

  • News
    news
  • TV
    TV
  • Radio
    Radio
  • Conference Hub
    Conf hub
  • Originals
    Originals

Partners links

  • Advances
    Advances

User imageSign in

Register

Additional navigation- 1

  • Acute Basal Cell Carcinoma
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Breast Cancer
  • Early Breast Cancer
  • CAR-T Cell Therapy
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous Squamous-Cell Carcinoma
  • Diffuse Large B-Cell Lymphoma
  • FDA Approvals
  • Febrile Neutropenia
  • Follicular Lymphoma
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Healthcare Policy
  • Hematologic Malignancies
  • Immuno Oncology
  • Liver Cancer
  • Lung Cancer
  • Lymphoma
  • Multiple Myeloma
  • Myelofibrosis
  • Non-Small Cell Lung Cancer
  • Oncology Nursing
  • Pediatric Oncology
  • Radiation Oncology
  • Renal Cell Carcinoma
  • Sarcoma
  • Supportive Care
  • Surgical Oncology
  • Urethral Carcinoma